Dare Price Earnings Ratio from 2010 to 2025
| DARE Stock | USD 2.95 0.05 1.72% |
Price Earnings Ratio | First Reported 2010-12-31 | Previous Quarter (6.54) | Current Value (6.87) | Quarterly Volatility 24.20170058 |
Check Dare Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dare Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.2 K, Interest Expense of 528.6 M or Total Revenue of 10.3 M, as well as many indicators such as Price To Sales Ratio of 2.6 K, Dividend Yield of 0.19 or Days Sales Outstanding of 12.4 K. Dare financial statements analysis is a perfect complement when working with Dare Bioscience Valuation or Volatility modules.
Dare | Price Earnings Ratio |
Latest Dare Bioscience's Price Earnings Ratio Growth Pattern
Below is the plot of the Price Earnings Ratio of Dare Bioscience over the last few years. It is Dare Bioscience's Price Earnings Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dare Bioscience's overall financial position and show how it may be relating to other accounts over time.
| Price Earnings Ratio | 10 Years Trend |
|
Price Earnings Ratio |
| Timeline |
Dare Price Earnings Ratio Regression Statistics
| Arithmetic Mean | (11.97) | |
| Geometric Mean | 2.91 | |
| Coefficient Of Variation | (202.12) | |
| Mean Deviation | 15.42 | |
| Median | (2.93) | |
| Standard Deviation | 24.20 | |
| Sample Variance | 585.72 | |
| Range | 91.0244 | |
| R-Value | 0.32 | |
| Mean Square Error | 561.46 | |
| R-Squared | 0.11 | |
| Significance | 0.22 | |
| Slope | 1.65 | |
| Total Sum of Squares | 8,786 |
Dare Price Earnings Ratio History
About Dare Bioscience Financial Statements
Dare Bioscience stakeholders use historical fundamental indicators, such as Dare Bioscience's Price Earnings Ratio, to determine how well the company is positioned to perform in the future. Although Dare Bioscience investors may analyze each financial statement separately, they are all interrelated. For example, changes in Dare Bioscience's assets and liabilities are reflected in the revenues and expenses on Dare Bioscience's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Dare Bioscience. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price Earnings Ratio | (6.54) | (6.87) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Dare Bioscience Correlation against competitors. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dare Bioscience. If investors know Dare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dare Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.48) | Revenue Per Share | Quarterly Revenue Growth (0.96) | Return On Assets | Return On Equity |
The market value of Dare Bioscience is measured differently than its book value, which is the value of Dare that is recorded on the company's balance sheet. Investors also form their own opinion of Dare Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Dare Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dare Bioscience's market value can be influenced by many factors that don't directly affect Dare Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dare Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dare Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dare Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.